Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) Share Price

Company Profile

Business description
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
Contact
No. 99 Waisha Road
Jiaojiang District, Zhejiang Province
Taizhou318000
CHN
T: +86 57688706789
https://www.jiuzhoupharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
5,001

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,024.20	27.20	-0.30%
CAC 40	8,227.32	70.89	0.87%
DAX 40	24,155.45	39.45	-0.16%
Dow JONES (US)	49,310.32	179.71	-0.36%
FTSE 100	10,457.01	19.45	-0.19%
HKSE	25,915.20	248.04	-0.95%
NASDAQ	24,438.50	219.06	-0.89%
Nikkei 225	59,140.23	445.63	-0.75%
NZX 50 Index	12,881.11	3.82	-0.03%
S&P 500	7,108.40	29.50	-0.41%
S&P/ASX 200	8,793.40	26.10	-0.30%
SSE Composite Index	4,093.25	13.01	-0.32%